Fragment-based drug discovery (FBDD) has emerged as a powerful and efficient approach in modern pharmaceutical research, enabling scientists to identify high-quality lead compounds with improved precision and success rates. By screening low-molecular-weight chemical fragments that bind to biological targets, FBDD allows for the rational design of potent and selective drug candidates. Driven by...